Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Multifamily group psychoeducation [MFG] and group cognitive behavioral therapy [GCBT] are evidence-based treatments for first episode psychosis. However, like all treatments for psychotic disorders, neither MFG nor GCBT are perfect-some individuals who receive these interventions still experience a worsening of psychotic symptoms. Clarifying the mechanisms through which these interventions produce their clinical benefits and identifying the factors that may maximize an individual's response to MFG and GCBT could improve the clinical benefits facilitated by these two interventions.
Background
There is growing evidence that the majority of the psychosocial deterioration that accompanies psychotic disorders occurs during the first few years of illness and that the prevention or delay of early deterioration may be associated with a better course of illness. Two interventions which have been shown to improve the course of recent-onset psychosis are multifamily group psychoeducation [MFG] and group cognitive behavioral therapy [GCBT]. Both family psychoeducation and cognitive behavioral therapy have been recommended as components of usual care for psychotic disorders by the Schizophrenia Patient Oriented Research Team convened by the U.S. Department of Health and Human Services (10) as well as other international health organizations. However, like all treatments for psychotic disorders, neither MFG nor GCBT are perfect-some individuals who receive these interventions still experience a worsening of psychotic symptoms. Clarifying the mechanisms through which these interventions produce their clinical benefits and identifying the factors that may maximize an individual's response to MFG and GCBT could improve the clinical benefits facilitated by these two interventions.
Purpose and Objectives
The goal of this study is to clarify the mechanisms through which MFG and GCBT produce their clinical benefits (i.e., mediators) and identify the factors that may maximize an individual's response to these two empirically-validated interventions (i.e., moderators).
Methods
All participants will be provided with 2 years of of GCBT and MFG and will complete regular assessments with regard to clinical and functional outcomes as well as potential mediators and moderators of these outcomes.
Significance of the Study
Clarifying the mechanisms through which these interventions produce their clinical benefits and identifying the factors that may maximize an individual's response to MFG and GCBT could lead to improvements in the treatment of first-episode psychosis.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| MFG and GCBT | Other | There is a single arm for this study. All participants will be able to participate in MFG and GCBT |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Group Cognitive Behavioral Therapy | Behavioral | weekly |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline in General level of functioning at 6 months, 12 months, 18 months, and 24 months | General level of functioning to be assessed using the General Assessment of Functioning (GAF) scale | Baseline, 6 months, 12 months, 18 months, 24 months |
| Change from baseline in self-reported Physical Health at 6 months, 12 months, 18 months, and 24 months | Self-reported physical health assessed using the RAND-36 Health Survey | Baseline, 6 months, 12 months, 18 months, 24 months |
| Change from baseline in Social and vocational Functioning at 6 months, 12 months, 18 months, and 24 months | Social and Vocational functioning to be assessed using the Social Functioning Scale | Baseline, 6 months, 12 months, 18 months, 24 months |
| Change from baseline in Stage of Recovery at 6 months, 12 months, 18 months, and 24 months | Stage of recovery assessed using the Stage of Recovery Instrument | Baseline, 6 months, 12 months, 18 months, 24 months |
| Change from baseline Service Utilization at 6 months, 12 months, 18 months, and 24 months | Service utilization as assessed using the Service Utilization Record Form | Baseline, 6 months, 12 months, 18 months, 24 months |
| Change from Baseline Quality of Life at 6 months, 12 months, 18 months, and 24 months | Quality of Life as assessed using the WHO Quality of Life Scale Brief | Baseline, 6 months, 12 months, 18 months, 24 months |
Not provided
Not provided
Inclusion Criteria (Individual with Recent-Onset Psychosis):
Exclusion Criterion (Individual with Recent Onset Psychosis)
Inclusion Criteria (Family Caregiver):
Exclusion Criterion (Family Caregiver)
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Nicholas Breitborde, Ph.D. | The Ohio State Univerity | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Arizona Department of Psychiatry | Tucson | Arizona | 85724 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 38053744 | Derived | Moe AM, Wastler HM, Pine JG, Breitborde NJK. Metacognitive Skills Training and Computerized Cognitive Remediation among Individuals with First-Episode Psychosis: Influence on Social Cognition. Psychosis. 2023;15(4):418-423. doi: 10.1080/17522439.2022.2111595. Epub 2023 Jan 4. | |
| 34210341 | Derived | Breitborde NJK, Bell EK, Woolverton C, Pine JG, Waslter H, Moe AM. Cost Utility of cognition-enhancing interventions for individuals with first-episode psychosis: a naturalistic evaluation. Cost Eff Resour Alloc. 2021 Jul 1;19(1):36. doi: 10.1186/s12962-021-00292-6. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Multifamily Group Psychoeducation |
| Behavioral |
twice monthly |
|
| 26511605 | Derived | Breitborde NJ, Bell EK, Dawley D, Woolverton C, Ceaser A, Waters AC, Dawson SC, Bismark AW, Polsinelli AJ, Bartolomeo L, Simmons J, Bernstein B, Harrison-Monroe P. The Early Psychosis Intervention Center (EPICENTER): development and six-month outcomes of an American first-episode psychosis clinical service. BMC Psychiatry. 2015 Oct 28;15:266. doi: 10.1186/s12888-015-0650-3. |
| ID | Term |
|---|---|
| D012559 | Schizophrenia |
| D011618 | Psychotic Disorders |
| ID | Term |
|---|---|
| D019967 | Schizophrenia Spectrum and Other Psychotic Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided